Practice variation and limited adoption of evidence in POPF prevention after pancreatoduodenectomy: an international E-AHPBA-endorsed survey
HPB · 2026
DOI: 10.1016/j.hpb.2026.06.011 ↗Kurz gefasst
Fachartikel in der Zeitschrift HPB, 2026. Verfasst von Michael Hoffmann und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of General, Visceral, Transplant and Thoracic Surgery, University Hospital Augsburg, Germany. Electronic address: michael.hoffmann@uk-augs…. Hauptthemen laut MEDLINE: Pancreaticoduodenectomy, Pancreatic Fistula, Practice Patterns, Physicians'. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND: Postoperative pancreatic fistula (POPF) remains a major source of morbidity after pancreatoduodenectomy. This international survey assessed contemporary preventive strategies and practice variation. METHODS: An online survey was distributed to HPB surgeons worldwide. The questionnaire addressed risk assessment, anastomotic technique, pancreatic duct stenting, drain management, antibiotic prophylaxis and somatostatin analogue use. Responses were analysed descriptively. RESULTS: 283 surgeons from 48 countries completed the survey. Intraoperative POPF risk assessment was routinely performed by 228/283 respondents (80.6%), yet formal risk tools were used inconsistently. Pancreatic reconstruction was largely uniform, with pancreatojejunostomy performed by 252/283 surgeons (89.0%). Pancreatic duct stenting showed marked variation, with 160/283 respondents (56.5%) reporting routine or frequent use and internal stents preferred by 179/227 surgeons (78.9%). Almost all respondents used intra-abdominal drains (279/283, 98.6%), but the timing of drain removal varied substantially. Ureidopenicillins were used as antibiotic prophylaxis by 120/268 respondents (44.8%), whereas 95/268 (35.4%) used second-generation cephalosporins. Somatostatin analogue use was highly heterogeneous. DISCUSSION: Preventive strategies against POPF vary widely across institutions. Heterogeneity persists even in areas supported by randomized evidence, highlighting important gaps between available data and routine clinical practice and identifying priorities for future interventional studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of General, Visceral, Transplant and Thoracic Surgery, University Hospital Augsburg, Germany. Electronic address: michael.hoffmann@uk-augsburg.de.
- Department of General, Visceral, Transplant and Thoracic Surgery, University Hospital Augsburg, Germany.
- Department of General, Visceral, Thoracic and Minimally-Invasive Surgery, City Hospital Bad Tölz, Germany.
Zitieren
APA
Hoffmann, M., Anthuber, L., Wolf, S., Schrempf, M., Sommer, F., Lauscher, J., Anthuber, M., Beyer, K., & Pinto, D. (2026). Practice variation and limited adoption of evidence in POPF prevention after pancreatoduodenectomy: an international E-AHPBA-endorsed survey. HPB. https://doi.org/10.1016/j.hpb.2026.06.011
Vancouver
Hoffmann M, Anthuber L, Wolf S, Schrempf M, Sommer F, Lauscher J, et al. Practice variation and limited adoption of evidence in POPF prevention after pancreatoduodenectomy: an international E-AHPBA-endorsed survey. HPB. 2026. doi:10.1016/j.hpb.2026.06.011
BibTeX
@article{Hoffmann2026,
author = {Hoffmann, Michael and Anthuber, Lena and Wolf, Sebastian and Schrempf, Matthias and Sommer, Florian and Lauscher, Johannes and Anthuber, Matthias and Beyer, Katharina and Pinto, David},
title = {Practice variation and limited adoption of evidence in POPF prevention after pancreatoduodenectomy: an international E-AHPBA-endorsed survey},
journal = {HPB},
year = {2026},
doi = {10.1016/j.hpb.2026.06.011}
}
EUVIMED